Newbury Street II Acquisition Corp is a special purpose acquisition company formed to identify and complete a business combination with one or more operating businesses through a merger or similar transaction. It has no current operating activities.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 0 | — | 1.7 | — |
| Q3 2025 | 0 | — | 1.7 | — |
| Q4 2025 | 0 | — | 1.5 | — |
| Q1 2026 | 0 | — | 1.4 | — |
| Q2 2026 | 0 | — | 0.3 | -81.5% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Prelude Therapeutics Incorporated (PRLD), TRG Latin America Acquisitions Corp. (TRGS), Omega Flex, Inc. (OFLX), Vendome Acquisition Corporation I (VNME), EyePoint, Inc. (EYPT), Upstream Bio, Inc. (UPB)